Clinical trial
A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature…
NCT00210613 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00210613 |
|---|---|
| Title | A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation |
| Official title | A Placebo-Controlled, Double-Blind, Randomized, Parallel Study of the Withdrawal Effects of Chronic Daily and As-Needed Dosing With Dapoxetine in the Treatment of Premature Ejaculation |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sexual Dysfunction, Ejaculation |
| Intervention type | Drug |
| Interventions | Dapoxetine |
| Enrollment | 199 |
| Start date | Nov 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: